NASDAQ : BLRX

BioLineRx Ltd. — Financial statements

Healthcare · Biotechnology · Israel

Last price 1.99 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 10.41M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

BioLineRx Ltd. (BLRX) reported revenue of 1.39M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue1.39M1.18M28.94M4.80M
Cost of Revenue278.00K230.00K9.26M3.69M
Gross Profit1.11M950.00K19.68M1.11M
Selling, General & Admin3.67M3.14M29.68M31.58M11.53M5.31M
Research & Development9.62M8.09M9.15M12.52M17.63M19.47M
Operating Expenses13.28M11.24M38.83M44.10M29.16M24.78M
Operating Income-12.17M-10.29M-19.15M-42.99M-29.16M-24.78M
Interest Expense-1.01M-1.25M-9.07M-2.14M-1.79M-984.00K
Interest & Investment Income680.00K1.12M1.82M2.01M694.00K277.00K
Currency Exchange Gain (Loss)340.00K340.00K51.00K61.00K-346.00K282.00K
Other Non Operating Income (Expenses)2.02M8.05M18.39M-10.84M5.64M-1.85M
EBT Excluding Unusual Items-10.14M-2.03M-7.96M-53.91M-24.95M-27.05M
Asset Writedown-1.26M-6.70M
Pretax Income-10.14M-2.03M-9.22M-60.61M-24.95M-27.05M
Earnings From Continuing Operations-10.14M-2.03M-9.22M-60.61M-24.95M-27.05M
Minority Interest in Earnings3.15M851.00K
Net Income-6.99M-1.18M-9.22M-60.61M-24.95M-27.05M
Net Income to Common-6.99M-1.18M-9.22M-60.61M-24.95M-27.05M
Shares Outstanding (Basic)2.65B2.47B1.20B963.37M773.96M662.93M
Shares Outstanding (Diluted)2.65B2.47B1.20B963.37M773.96M662.93M
EPS (Basic)-0.00-0.00-0.01-0.06-0.03-0.04
EPS (Diluted)-0.00-0.00-0.01-0.06-0.03-0.04
Free Cash Flow-10.83M-8.10M-43.93M-22.72M-26.37M-23.67M
Free Cash Flow Per Share-0.00-0.00-0.04-0.02-0.03-0.04
Gross Margin80.03%80.51%67.99%23.08%
Operating Margin-874.28%-871.78%-66.18%-895.65%
Profit Margin-502.08%-99.58%-31.86%-1,262.79%
Free Cash Flow Margin-777.87%-686.36%-151.78%-473.42%
EBITDA-12.12M-10.06M-15.16M-41.61M-28.50M-24.07M
EBITDA Margin-52.38%
D&A For EBITDA52.00K227.00K3.99M1.38M654.00K703.00K
EBIT-12.17M-10.29M-19.15M-42.99M-29.16M-24.78M
EBIT Margin-66.18%
Revenue as Reported1.18M1.18M28.94M4.80M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents4.63M3.25M10.44M4.25M10.59M12.99M
Short-Term Investments8.45M17.63M9.13M38.74M40.49M44.15M
Cash & Short-Term Investments13.08M20.88M19.56M42.99M51.08M57.13M
Accounts Receivable46.00K2.48M358.00K
Other Receivables728.00K410.00K1.39M350.00K721.00K142.00K
Receivables728.00K456.00K3.86M708.00K721.00K142.00K
Inventory2.17M2.15M3.15M1.95M
Prepaid Expenses376.00K201.00K443.00K1.05M198.00K127.00K
Other Current Assets91.00K480.00K
Total Current Assets16.35M23.68M27.10M47.18M52.00M57.40M
Property, Plant & Equipment803.00K856.00K1.35M1.89M2.50M2.28M
Other Intangible Assets16.33M16.37M10.45M14.85M21.89M21.70M
Total Assets33.48M40.91M38.91M63.92M76.38M81.39M
Accounts Payable4.29M3.49M5.58M10.87M6.97M5.57M
Accrued Expenses1.21M3.13M3.27M1.66M1.23M
Current Portion of Long-Term Debt4.48M4.48M4.48M3.15M1.54M2.76M
Current Portion of Leases280.00K234.00K522.00K528.00K427.00K168.00K
Current Unearned Revenue12.96M
Other Current Liabilities4.63M2.71M1.69M12.02M84.00K2.00K
Total Current Liabilities13.68M12.12M15.41M42.78M10.68M9.72M
Long-Term Debt2.22M4.46M8.96M6.63M8.63M
Long-Term Leases962.00K977.00K1.08M1.29M1.73M1.73M
Other Long-Term Liabilities4.51M1.86M
Total Liabilities16.86M17.56M25.45M50.70M25.54M13.30M
Common Stock73.78M73.43M38.10M31.36M27.10M21.07M
Additional Paid-In Capital327.93M327.58M353.69M355.48M338.98M339.35M
Retained Earnings-405.63M-401.00M-399.83M-390.61M-329.99M-305.04M
Comprehensive Income & Other17.70M18.19M21.50M16.99M14.76M12.72M
Total Common Equity13.77M18.20M13.46M13.22M50.84M68.09M
Minority Interest2.85M5.15M
Shareholders' Equity16.62M23.34M13.46M13.22M50.84M68.09M
Total Liabilities & Equity33.48M40.91M38.91M63.92M76.38M81.39M
Total Debt7.94M10.15M15.04M11.59M12.32M4.65M
Net Cash (Debt)5.14M10.73M4.52M31.40M38.76M52.48M
Net Cash Per Share0.000.000.000.030.050.08
Filing Date Shares Outstanding2.62B2.61B2.23B1.09B922.96M715.16M
Total Common Shares Outstanding2.62B2.61B1.34B1.09B922.96M715.16M
Working Capital2.67M11.56M11.70M4.40M41.32M47.69M
Book Value Per Share0.010.010.010.010.060.10
Tangible Book Value-2.56M1.83M3.01M-1.63M28.96M46.38M
Tangible Book Value Per Share-0.000.000.00-0.000.030.06
Machinery2.11M2.29M2.93M2.81M2.66M
Leasehold Improvements2.04M2.04M2.04M2.04M2.03M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-6.99M-1.18M-9.22M-60.61M-24.95M-27.05M
Depreciation & Amortization266.00K441.00K3.99M1.38M654.00K703.00K
Other Amortization82.00K784.00K742.00K171.00K
Loss (Gain) From Sale of Assets25.00K25.00K
Asset Writedown & Restructuring Costs1.26M6.70M
Stock-Based Compensation306.00K396.00K1.14M2.32M2.25M1.50M
Other Operating Activities-5.19M-9.80M-19.96M12.40M-5.60M1.82M
Change in Accounts Receivable32.00K2.43M-2.12M-358.00K
Change in Inventory683.00K997.00K-1.19M-1.95M
Change in Accounts Payable268.00K-3.48M-5.51M5.51M1.89M-564.00K
Change in Unearned Revenue-12.96M12.96M
Change in Other Net Operating Assets-283.00K1.31M-43.00K-959.00K-650.00K24.00K
Operating Cash Flow-10.80M-8.07M-43.87M-22.61M-26.24M-23.57M
Capital Expenditures-25.00K-25.00K-53.00K-116.00K-131.00K-97.00K
Sale (Purchase) of Intangibles-2.00K-2.00K-1.00K-181.00K-185.00K
Investment in Securities12.43M-8.52M29.43M1.74M4.32M-38.13M
Investing Cash Flow12.39M-8.54M29.37M1.44M4.01M-38.22M
Long-Term Debt Issued19.22M9.13M
Long-Term Debt Repaid-5.01M-14.94M-1.99M-3.05M-3.57M
Lease Payments-374.00K-512.00K-511.00K-445.00K-220.00K-196.00K
Net Debt Issued (Repaid)-4.87M-5.01M4.28M-1.99M6.07M-3.57M
Issuance of Common Stock384.00K13.89M16.38M17.04M14.36M61.32M
Financing Cash Flow-4.49M8.88M20.66M15.06M20.44M57.75M
Foreign Exchange Rate Adjustments342.00K549.00K22.00K-224.00K-607.00K207.00K
Net Cash Flow-2.56M-7.19M6.18M-6.33M-2.40M-3.84M
Free Cash Flow-10.83M-8.10M-43.93M-22.72M-26.37M-23.67M
Free Cash Flow Margin-777.87%-686.36%-151.78%-473.42%
Free Cash Flow Per Share-0.00-0.00-0.04-0.02-0.03-0.04
Levered Free Cash Flow-8.85M-3.88M-43.89M2.33M-15.32M-14.54M
Unlevered Free Cash Flow-8.22M-3.09M-38.21M3.67M-14.20M-13.92M
Free Cash Flow After Leases-11.20M-8.61M-44.44M-23.17M-26.59M-23.87M
Cash Interest Paid1.04M1.27M10.39M1.11M593.00K682.00K
Change in Working Capital700.00K1.26M-21.82M15.20M1.24M-540.00K

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization9.50M13.10M23.49M115.26M28.47M99.33M
Enterprise Value7.33M-1.26M23.94M101.85M-18.57M40.42M
Last Close Price1.992.778.5662.8023.6081.60
PS Ratio6.8311.100.8124.01
PB Ratio0.570.561.758.720.561.46
P/TBV Ratio7.177.800.982.14
EV/Sales Ratio5.270.8321.22
Debt / Equity Ratio0.480.431.120.880.240.07
Net Debt / Equity Ratio-0.31-0.46-0.34-2.38-0.76-0.77
Net Debt / EBITDA Ratio0.421.070.300.761.362.18
Net Debt / FCF Ratio0.471.320.101.381.472.22
Asset Turnover0.040.030.560.07
Inventory Turnover0.110.093.63
Quick Ratio1.011.761.521.024.855.89
Current Ratio1.201.951.761.104.875.91
Return on Equity (ROE)-55.27%-11.01%-69.11%-189.23%-41.96%-60.04%
Return on Assets (ROA)-19.82%-16.11%-23.28%-38.30%-23.10%-24.07%
Return on Capital Employed (ROCE)-61.50%-35.70%-81.50%-203.40%-44.40%-34.60%
Earnings Yield-75.42%-8.97%-39.26%-52.59%-87.63%-27.24%
FCF Yield-113.95%-61.81%-187.02%-19.72%-92.62%-23.83%
Buyback Yield / Dilution-49.34%-105.76%-24.37%-24.47%-16.75%-162.19%